The "Regional Resilience" Pivot: How 2026 is Ending the Single-Source Supply Crisis. As we move through 2026, the industry is undergoing a "Geographic Metamorphosis." This year, the Biotherapeutics Cell Line Development Market has reached a "Diversification Milestone," where over 30% of new capacity is being built in regional clusters like Singapore, Brazil, and the MENA region. This is proving essential for the 2026 "Sovereignty Mandate," as countries seek to reduce exposure...
0 แชร์
796 ยอดวิว
0 รีวิว
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
